Monday, March 3, 2025 – New to Pink Sheet? · US FDA Employs Familiar Strategy In Ending Novo's Wegovy, Ozempic Shortage · US FDA Takes Lilly's Mounjaro, Zepbound Off Shortage ...
Monday, March 3, 2025 – The Zepbound line extension and price reductions are aimed to appeal to self-pay customers. (Shutterstock). Eli Lilly is introducing reduced price ...
Monday, March 3, 2025 – Are GLP-1 therapies truly safe for long-term cardiovascular health? Dr Pandey unpacks key gaps in current research, real-world data, ...
Monday, March 3, 2025 – A local surgeon finds GLP 1 helps his patients who need knee and hip replacements.
Monday, March 3, 2025 – ... of the shortage for popular GLP-1 weight loss drugs Ozempic and Wegovy, the Alliance for Safe Biologic ...
Monday, March 3, 2025 – In a partnership marking AbbVie's entrance into the weight management field, the US pharma major has signed a licensing deal with Denmark's Gubra ...
Monday, March 3, 2025 – ... Zepbound, which are based on the GLP-1 hormone. This differentiation could provide AbbVie with a unique foothold in the competitive landscape. On ...
Monday, March 3, 2025 – ... GLP-1.” “Our population is getting healthier. You don't have to be a full-fledged diabetic with heart failure, or risk, to benefit from GLP-1.
Monday, March 3, 2025 – Arlin Wasserman questions the viewpoint that GLP-1 drugs will have a major impact on the food industry.
Monday, March 3, 2025 – Food manufacturers are responding to the growing popularity of GLP-1 drugs with product innovations designed to support consumers in their weight ...